Oaktree Acquisition Corp. III Life Sciences reports unregistered equity sale

Oaktree Acquisition Corp. III Life Sciences filed an 8-K covering an unregistered sale of equity securities, charter, bylaw or fiscal-year changes, and a shareholder vote. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.